LONDON – A more effective coronovirus vaccine has been discovered in European stocks on Tuesday amid growing optimism, and the Trump administration has accepted President-Elect Joe Biden’s transition to office.
Tracking European market American stock futures Which climbed into Monday night business after a strong session on Wall Street, sparked by positive vaccine news from AstraZeneca, Interim analysis revealed that its coronavirus vaccine has an average efficacy of 70%. The news followed strong results from Pfizer-BioNotech and Modern about their vaccine candidates.
Profit in futures also came later General Services Administration chief Emily Murphy told President-Elect Joe Biden The Trump administration is providing federal resources for its transformation into office.
Murphy had deferred his decision about Biden’s election victory for weeks after the November 3 election; President Donald Trump soon tweeted that he had approved the move.
News of Biden choosing former US Fed Chair Yellen as Treasury Secretary may spark investor sentiments on Tuesday. If confirmed by the Senate, she is set to be the first woman to head the department. Japan shares gained gains in the Asia-Pacific markets in Tuesday trading.
There are no major earnings from Europe on Tuesday; On the data front, Germany’s Ifo Institute releases the latest occupational climate survey results.
Subscribe to CNBC PRO to access Live Pro Talk including us 2 December 2 Discussion on opportunities and risks in international markets.
– CNBC’s Yun Li and Kevin Bruninger contributed to reporting this story.
“Wannabe troublemaker. Pop culture fanatic. Zombie nerd. Lifelong bacon advocate. Alcohol enthusiast. Tv junkie.”